eye health

Horizon looks to the future with massive San Francisco manufacturing, R&D plant
Horizon looks to the future with massive San Francisco manufacturing, R&D plant
Fierce Pharma
Horizon Therapeutics
eye health
R&D
drug manufacturing
Rare Diseases
San Francisco
Flag link:
Artificial Intelligence tech tool can now detect nearly 50 eye diseases faster than human doctors
Artificial Intelligence tech tool can now detect nearly 50 eye diseases faster than human doctors
Forbes
artificial intelligence
eye diseases
Google DeepMind
devices
eye health
Flag link:
EyeGate shares jump on data for eye treatment data
EyeGate shares jump on data for eye treatment data
Marketwatch
EyeGate Pharma
corneal wound repair
eye health
Flag link:
Biogen turns to eye, immune diseases to balance neuro gamble
Biogen turns to eye, immune diseases to balance neuro gamble
Biopharma Dive
Biogen
immune system
eye health
Neuroscience
Flag link:
Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases
Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases
BioSpace
Clover Therapeutics
start-ups
eye health
Genentech
Ocular Disease
Flag link:
Alcon Beats Expectations Since its Split from Novartis
Alcon Beats Expectations Since its Split from Novartis
Medical Devices and Diagnostics Industry
Alcon
earnings
Novartis
eye health
Flag link:
ReNeuron climbs on up dated vision loss cell therapy data
ReNeuron climbs on up dated vision loss cell therapy data
Fierce Biotech
ReNeuron
eye health
cell therapy
Retinitis pigmentosa
Flag link:
Glaukos touts 5-year study of glaucoma stents
Glaukos touts 5-year study of glaucoma stents
Mass Device
Glaukos
iStent
glaucoma
eye health
devices
Flag link:
Lukewarm data for Second Sight
Lukewarm data for Second Sight
EP Vantage
Second Sight
retinal prosthesis
Argus II
blindness
eye health
Flag link:
Novartis completes spin-out of Alcon eye unit
Novartis completes spin-out of Alcon eye unit
Pharmaforum
Novartis
Alcon
spinoffs
eye health
Flag link:
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases
Xconomy
Alnylam
Regeneron
RNAi
eye health
brain diseases
Flag link:
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Medical Devices and Diagnostics Industry
eye health
artificial intelligence
Roche
Genentech
diabetic macular edema
Flag link:
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
Xconomy
Aldeyra Therapeutics
clinical trials
FDA
eye health
reproxalap
seasonal allergic conjunctivitis
Flag link:
Novartis says listing of Alcon eye care business expected on April 9
Novartis says listing of Alcon eye care business expected on April 9
Yahoo/Reuters
Alcon
Novartis
spinoffs
eye health
Flag link:
Ophthalmic Medtech Company Avedro Launches $92 Million IPO
Ophthalmic Medtech Company Avedro Launches $92 Million IPO
CP Wire
Avedro
IPOs
eye health
corneal ectatic disorders
Flag link:
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy
Endpoints
Aurinia Pharmaceuticals
voclosporin
eye health
dry eye disease
Allergan
Restasis
Flag link:
Novartis unit Alcon picks up Tear Film Innovations
Novartis unit Alcon picks up Tear Film Innovations
Mass Device
Novartis
Alcon
M&A
eye health
Tear Film Innovations
devices
Flag link:
Alcon's Acquisition Is a Real Tear-Jerker
Alcon's Acquisition Is a Real Tear-Jerker
Medical Devices and Diagnostics Industry
Alcon
Novartis
eye health
Flag link:
Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects
Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects
Fierce Pharma
Novartis
Alcon
spinoffs
SEC
eye health
Flag link:
New eye health companies gain funders’ focus
New eye health companies gain funders’ focus
Medical Design and Outsourcing
eye health
Flag link:

Pages